Zydus Wellness Ltd
Zydus Wellness Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #22 of 31 in Food Products
See the sector's top 10 — free with your mobile number.
Zydus Wellness Ltd Q2 FY27 key numbers
- Revenue
- Adjusted Net Profit for Q2 FY27: INR 545 million, a >100% increase YoY.
As stated in Zydus Wellness Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.
Based on Zydus Wellness Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26. EBITDA for Q2 FY27: INR 855 million, a 271.7% year-on-year (YoY) increase from INR 230 million in Q2 FY26.
From Zydus Wellness Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Zydus Wellness' revenue grow in the September 2026 quarter?
- Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26.
- Revenue from Operations for Q2 FY27: INR 11,266 million, up 73.2% YoY from INR 6,505 million in Q2 FY26.
- Adjusted Net Profit for Q2 FY27: INR 545 million, a >100% increase YoY.
- Adjusted EPS for Q2 FY27: INR 1.71, compared to zero in Q2 FY26.
- Domestic market saw a 29.2% revenue increase in Q2 FY27.
2 more points from Zydus Wellness Ltd's call on revenue
Create a free account to keep reading this call
What happened to Zydus Wellness' margins in Q2 FY27?
See what Zydus Wellness Ltd said on profitability & margins — free account, 30 seconds.
What capex is Zydus Wellness planning?
See what Zydus Wellness Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Zydus Wellness raising money or cutting debt?
See what Zydus Wellness Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Zydus Wellness' order book?
See what Zydus Wellness Ltd said on order book & pipeline — free account, 30 seconds.
Zydus Wellness Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹1.4K Cr, net profit ₹119 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Zydus Wellness's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Food Products this season
- Hoac Foods (Q2 FY27)
Revenue from operations (gross) for the quarter ended September 30, 2026, is ₹2,326.15 lakh (Standalone) and ₹2,314.04 lakh (Consolidated). Key results statemen
- Narmada Agrobase (Q2 FY27)
EBITDA for the quarter ended September 30, 2026: ₹2303.54 lakhs, up from ₹2153.41 lakhs in the same quarter last year (YoY increase). Key results statement take
- Dangee Dums (Q2 FY27)
700.42 lakhs for the quarter ended September 30, 2025, reflecting a year-on-year increase of approximately 13.37%. Key results statement takeaways from Dangee D
- Megastar Foods Ltd (Q2 FY27)
Revenue from Operations for the quarter ended Sept 30, 2026 is ₹13,726.75 lakhs (as per standalone) and ₹17,267.8 lakhs (as per consolidated financials). Key…
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Zydus Wellness Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Zydus Wellness Ltd Q2 FY27 results?
Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26. EBITDA for Q2 FY27: INR 855 million, a 271.7% year-on-year (YoY) increase from INR 230 million in Q2 FY26.
What is Zydus Wellness Ltd share price analysis?
Zydus Wellness Ltd currently shows a neutral. The stock trades at a P/E of 69.4 with a market cap of ₹15,377 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Zydus Wellness Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.